questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité retardée
Sarcoïdose
Sarcoïdose pulmonaire
Sarcoïdose pulmonaire : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose pulmonaire : Questions médicales les plus fréquentes",
"headline": "Sarcoïdose pulmonaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sarcoïdose pulmonaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sarcoïdose",
"url": "https://questionsmedicales.fr/mesh/D012507",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose",
"code": {
"@type": "MedicalCode",
"code": "D012507",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire",
"alternateName": "Sarcoidosis, Pulmonary",
"code": {
"@type": "MedicalCode",
"code": "D017565",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert P Baughman",
"url": "https://questionsmedicales.fr/author/Robert%20P%20Baughman",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio."
}
},
{
"@type": "Person",
"name": "Dominique Valeyre",
"url": "https://questionsmedicales.fr/author/Dominique%20Valeyre",
"affiliation": {
"@type": "Organization",
"name": "Service de Pneumologie, INSERM UMR 1272, Université Sorbonne Paris Nord, AP-HP Hopital Avicenne, Bobigny, France."
}
},
{
"@type": "Person",
"name": "Jan C Grutters",
"url": "https://questionsmedicales.fr/author/Jan%20C%20Grutters",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands."
}
},
{
"@type": "Person",
"name": "Rohit Gupta",
"url": "https://questionsmedicales.fr/author/Rohit%20Gupta",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "Hilario Nunes",
"url": "https://questionsmedicales.fr/author/Hilario%20Nunes",
"affiliation": {
"@type": "Organization",
"name": "AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, 93009, France; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France. Electronic address: hilario.nunes@aphp.fr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Sex-Specific Bioaccumulation, Maternal Transfer, and Tissue Distribution of Legacy and Emerging Per- and Polyfluoroalkyl Substances in Snakes (",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36881938",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.est.2c09063"
}
},
{
"@type": "ScholarlyArticle",
"name": "Self-Emulsifying Drug Delivery System Enhances Tissue Distribution of Cinnamaldehyde by Altering the Properties of the Mucus Layer.",
"datePublished": "2022-09-21",
"url": "https://questionsmedicales.fr/article/36131215",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1208/s12249-022-02416-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changes in adipose tissue distribution and relation to cardiometabolic risk factors after Roux-en-Y gastric bypass in adolescents.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37296018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.soard.2023.04.326"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution-A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling.",
"datePublished": "2023-11-12",
"url": "https://questionsmedicales.fr/article/38003416",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms242216224"
}
},
{
"@type": "ScholarlyArticle",
"name": "Abnormal Biologic Distribution Related to Normal Saline Among",
"datePublished": "2022-10-04",
"url": "https://questionsmedicales.fr/article/36195444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnmt.122.264241"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité retardée",
"item": "https://questionsmedicales.fr/mesh/D006968"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sarcoïdose",
"item": "https://questionsmedicales.fr/mesh/D012507"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sarcoïdose pulmonaire",
"item": "https://questionsmedicales.fr/mesh/D017565"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sarcoïdose pulmonaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sarcoïdose pulmonaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sarcoïdose pulmonaire",
"description": "Comment diagnostiquer la sarcoïdose pulmonaire ?\nQuels tests sont utilisés pour le diagnostic ?\nLes tests sanguins sont-ils utiles ?\nQuelles sont les caractéristiques radiologiques ?\nLa biopsie est-elle toujours nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Tissue+Distribution&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sarcoïdose pulmonaire",
"description": "Quels sont les symptômes courants ?\nLa fatigue est-elle un symptôme ?\nY a-t-il des symptômes systémiques ?\nLes symptômes varient-ils d'un patient à l'autre ?\nLes symptômes peuvent-ils s'aggraver ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Tissue+Distribution&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sarcoïdose pulmonaire",
"description": "Peut-on prévenir la sarcoïdose pulmonaire ?\nY a-t-il des facteurs environnementaux à éviter ?\nLe tabagisme influence-t-il la sarcoïdose ?\nDes vaccinations sont-elles recommandées ?\nLe stress a-t-il un impact sur la maladie ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Tissue+Distribution&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sarcoïdose pulmonaire",
"description": "Quels traitements sont disponibles ?\nY a-t-il des traitements alternatifs ?\nLes traitements sont-ils toujours nécessaires ?\nComment surveiller l'efficacité du traitement ?\nLes effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Tissue+Distribution&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sarcoïdose pulmonaire",
"description": "Quelles sont les complications possibles ?\nLa sarcoïdose peut-elle affecter d'autres organes ?\nComment prévenir les complications ?\nLes complications sont-elles réversibles ?\nQuels sont les signes d'alerte des complications ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Tissue+Distribution&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sarcoïdose pulmonaire",
"description": "Quels sont les facteurs de risque connus ?\nL'exposition professionnelle est-elle un facteur ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Tissue+Distribution&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la sarcoïdose pulmonaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens cliniques, radiologiques et histologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la radiographie thoracique, la tomodensitométrie et la biopsie."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent aider à évaluer l'inflammation et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quelles sont les caractéristiques radiologiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On observe souvent des adénopathies hilaires et des infiltrats pulmonaires."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle toujours nécessaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais elle est souvent essentielle pour confirmer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux, l'essoufflement et la douleur thoracique."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est fréquente et peut être sévère chez les patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fièvre et la perte de poids peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent s'aggraver avec le temps ou lors de poussées."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la sarcoïdose pulmonaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention connue pour la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des agents irritants ou allergènes peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la sarcoïdose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut aggraver les symptômes et la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Des vaccinations sont-elles recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune vaccination spécifique n'est recommandée pour prévenir la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la maladie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, mais il ne cause pas la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes sont le traitement principal pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des immunosuppresseurs peuvent être utilisés si les corticostéroïdes sont inefficaces."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils toujours nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains patients peuvent ne pas nécessiter de traitement actif."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des examens cliniques et des tests de fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent causer des effets secondaires comme la prise de poids."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fibrose pulmonaire et l'insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "La sarcoïdose peut-elle affecter d'autres organes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut toucher les yeux, la peau, et le système nerveux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une aggravation de l'essoufflement ou de la douleur thoracique doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin et l'origine ethnique afro-américaine."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposent à des agents susceptibles de déclencher la maladie."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de sarcoïdose peut augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer la sarcoïdose que les hommes."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la sarcoïdose est plus fréquente chez les adultes jeunes et d'âge moyen."
}
}
]
}
]
}
The effects of sex and pregnancy on the bioaccumulation and tissue distribution of legacy and emerging per- and polyfluoroalkyl substances (PFASs) in Chinese water snakes were investigated. The bioacc...
Oral delivery is considered the preferred route of administration due to its convenience and favorable compliance. However, this delivery often faces difficulties, such as poor solubility, limited abs...
Roux-en-Y gastric bypass (RYGB) among adolescents with obesity results in significant weight loss; however, depot-specific changes have been understudied....
We hypothesized that visceral adipose tissue (VAT) reduction in adolescents undergoing RYGB would be greater than other depots and associated with improvement in cardiometabolic risk factors....
Three specialized treatment centers in Sweden....
Fifty-nine adolescents underwent dual x-ray absorptiometry before surgery and at 1, 2, and 5 years after RYGB. Changes in body composition in multiple depots (total fat, lean body, gynoid fat, android...
At 1 year post-RYGB, a significant reduction was observed across all body composition measures (P < .001) with the greatest reduction observed in VAT (-65.1% [-68.7, -61.8]). From year 1 to 5 years po...
Adiposity measures all decreased after RYGB but poorly predicted change in cardiometabolic risk. Despite significant reductions at 1 year, a steady regain was observed out to 5 years, with values stil...
A permeability-limited physiologically based pharmacokinetic (PBPK) model featuring four subcompartments (corresponding to the intracellular and extracellular water of the tissue, the residual plasma,...
The primary aim was to describe the incidence and causes of abnormal distribution of...
Transformable peptides (TPs) are biomedical materials with unique structures and diverse functionalities that have drawn great interest in materials science and nanomedicine. Here, we design a series ...
Controlling the biodistribution of protein- and nanoparticle-based therapeutic formulations remains challenging. In vivo library selection is an effective method for identifying constructs that exhibi...
To investigate the biodistribution and kinetic constants of...
Seven patients who experienced endoscopic resection of gastric neuroendocrine tumor were enrolled. Dynamic total-body PET/CT scans over 60 min were performed. Time-activity curves were obtained by dra...
The highest uptake of...
Uptake and clearance of...
White adipose tissue (WAT) usually shows negligible...
Tumor growth, progression, and metastatic capability in non-Hodgkin lymphomas (NHLs) are influenced by different component of tumor microenvironment, including inflammatory cells. Among these latter, ...